ArticlePloS one2025
Translation and validation of the artificial intelligence anxiety scale in German.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and validation of the student readiness and anxiety scale for AI-assisted biology teaching (SRAS-AIBT).Scientific reports · 2026Article
- Artificial intelligence anxiety: a narrative review of psychiatric conceptualization and clinical management.Journal of Yeungnam medical science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimArtificial intelligence anxiety refers to fear due to challenges caused by AI-related changes in one's own life. As the first study, our aim was to translate and validate the German version of the Artificial Intelligence Anxiety Scale (AIAS-G). Furthermore, norm values (i.e., reference scores derived from the population) were presented.
methodsData were used from a quota-based sample of the adult population in Germany spanning from 18 to 74 years (n = 3,270) reflecting the German population in terms of sex, age and federal state. Data were collected in January 2025. The translation process followed established guidelines. Reliability was determined (in terms of Cronbach's alpha and McDonald's omega). Confirmatory factor analysis was conducted to examine construct validity. Concurrent validity was investigated by calculating pairwise correlations of AIAS-G with depressive symptoms, anxiety symptoms, life satisfaction and ikigai (Japanese concept mainly referring to meaning/purpose in life). Moreover, norm values were offered (also for specific sociodemographic groups). The AIAS-G sum score ranges from 21 to 147, with higher values corresponding to a higher AI anxiety level.
resultsCronbach's alpha was .97 for the AIAS-G (subscales from .94 to .98). The mean AI anxiety level was 69.6 (SD: 32.6), with highest mean levels among women, older adults, individuals being divorced/widowed, individuals with low education, and retired individuals. The four-factor model originally proposed was substantiated by the findings of the confirmatory factor analysis. Higher levels of AI-related anxiety were associated with more depressive symptoms (r = .32, p < .001), more anxiety symptoms (r = .34, p < .001), lower life satisfaction (r = -.16, p < .001) and lower ikigai levels (r = -.21, p < .001).
conclusionThe AIAS-G is a psychometrically sound instrument designed to determine AI anxiety levels among German speakers. Further translation and validation studies are necessary to enable comparisons across various countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.